232 related articles for article (PubMed ID: 30384580)
1. Comparison of Breast Conserving Surgery Followed by Radiation Therapy with Mastectomy Alone for Pathologic N1 Breast Cancer Patients in the Era of Anthracycline Plus Taxane-Based Chemotherapy: A Multicenter Retrospective Study (KROG 1418).
Yoo GS; Park W; Yu JI; Choi DH; Kim YJ; Shin KH; Wee CW; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Cha J
Cancer Res Treat; 2019 Jul; 51(3):1041-1051. PubMed ID: 30384580
[TBL] [Abstract][Full Text] [Related]
2. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
[No Abstract] [Full Text] [Related]
3. Breast Conservation Therapy Versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23.
Kim K; Park HJ; Shin KH; Kim JH; Choi DH; Park W; Ahn SD; Kim SS; Kim DY; Kim TH; Kim JH; Kim J
Cancer Res Treat; 2018 Oct; 50(4):1316-1323. PubMed ID: 29334604
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.
Wang J; Wang S; Tang Y; Jing H; Sun G; Jin J; Liu Y; Song Y; Wang W; Fang H; Ren H; Yu Z; Li Y
Clin Breast Cancer; 2018 Oct; 18(5):e975-e984. PubMed ID: 30054238
[TBL] [Abstract][Full Text] [Related]
5. Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418).
Kim H; Park W; Yu JI; Choi DH; Huh SJ; Kim YJ; Lee ES; Lee KS; Kang HS; Park IH; Shin KH; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Lee JY
Oncotarget; 2017 Jan; 8(1):1796-1804. PubMed ID: 27793036
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline Plus Taxane-Based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study.
Kim H; Park W; Yu JI; Choi DH; Huh SJ; Kim YJ; Lee ES; Lee KS; Kang HS; Park IH; Shin KH; Wee CW; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Cha J
Cancer Res Treat; 2017 Oct; 49(4):970-980. PubMed ID: 28052649
[TBL] [Abstract][Full Text] [Related]
7. Protocol for the postoperative radiotherapy in N1 breast cancer patients (PORT-N1) trial, a prospective multicenter, randomized, controlled, non-inferiority trial of patients receiving breast-conserving surgery or mastectomy.
Lee TH; Chang JH; Jang BS; Kim JS; Kim TH; Park W; Kim YB; Kim SS; Han W; Lee HB; Shin KH
BMC Cancer; 2022 Nov; 22(1):1179. PubMed ID: 36384573
[TBL] [Abstract][Full Text] [Related]
8. Radiation pneumonitis in breast cancer patients treated with taxanes: does sequential radiation therapy lower the risk?
Beal K; Hudis C; Norton L; Wagman R; McCormick B
Breast J; 2005; 11(5):317-20. PubMed ID: 16174151
[TBL] [Abstract][Full Text] [Related]
9. Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.
Wang J; Yang SP; Zhou P; Lian CL; Lei J; Hua L; He ZY; Wu SG
Cancer Med; 2021 Mar; 10(5):1634-1643. PubMed ID: 33586323
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: A NCDB analysis.
Chen K; Liu J; Zhu L; Su F; Song E; Jacobs LK
Oncotarget; 2015 Nov; 6(37):40127-40. PubMed ID: 26517676
[TBL] [Abstract][Full Text] [Related]
11. The different outcomes between breast-conserving surgery plus radiotherapy and mastectomy in metaplastic breast cancer: A population-based study.
Xia LY; Xu WY; Hu QL
PLoS One; 2021; 16(9):e0256893. PubMed ID: 34473783
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for supraclavicular lymph node recurrence in N1 breast cancer patients.
Kong M; Hong SE
Asian Pac J Cancer Prev; 2013; 14(4):2509-14. PubMed ID: 23725165
[TBL] [Abstract][Full Text] [Related]
13. Mortality impact of less-than-standard therapy in older breast cancer patients.
Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
[TBL] [Abstract][Full Text] [Related]
14. Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418).
Kim YJ; Park W; Ha B; Park B; Joo J; Kim TH; Park IH; Lee KS; Lee ES; Shin KH; Kim H; Yu JI; Choi DH; Huh SJ; Wee CW; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Cha J
Cancer Res Treat; 2017 Oct; 49(4):927-936. PubMed ID: 28052654
[TBL] [Abstract][Full Text] [Related]
15. Survival After Breast-Conserving Surgery Compared with that After Mastectomy in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Gwark S; Kim HJ; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Ahn SH; Lee SB
Ann Surg Oncol; 2023 May; 30(5):2845-2853. PubMed ID: 36577865
[TBL] [Abstract][Full Text] [Related]
16. Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.
Sagara Y; Freedman RA; Vaz-Luis I; Mallory MA; Wong SM; Aydogan F; DeSantis S; Barry WT; Golshan M
J Clin Oncol; 2016 Apr; 34(11):1190-6. PubMed ID: 26834064
[TBL] [Abstract][Full Text] [Related]
17. Associated Factors and Survival Outcomes for Breast Conserving Surgery versus Mastectomy among New Zealand Women with Early-Stage Breast Cancer.
Abrahimi MS; Elwood M; Lawrenson R; Campbell I; Tin Tin S
Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33800387
[TBL] [Abstract][Full Text] [Related]
18. Impact of locoregional treatment on survival in patients presented with metastatic breast carcinoma.
Gultekin M; Yazici O; Eren G; Yuce D; Aksoy S; Ozisik Y; Guler N; Yazici G; Hurmuz P; Yildiz F; Altundag K; Gurkaynak M
Breast; 2014 Dec; 23(6):775-83. PubMed ID: 25201554
[TBL] [Abstract][Full Text] [Related]
19. Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
Choi SH; Kim JW; Choi J; Sohn J; Kim SI; Park S; Park HS; Jeong J; Suh CO; Keum KC; Kim YB; Lee IJ
Clin Breast Cancer; 2018 Apr; 18(2):e167-e178. PubMed ID: 28689012
[TBL] [Abstract][Full Text] [Related]
20. Does addition of postmastectomy radiotherapy improve outcome of patients with pT1-2, N0 triple negative breast cancer as compared to breast conservation therapy?
Raghavan RK; Ibrahim S; Jagathnath Krishna KM; Mathew BS
J Cancer Res Ther; 2019; 15(5):1031-1034. PubMed ID: 31603106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
